Structural Biology

Belgian researchers find a crack in the wall of WHO’s top priority pathogens

Belgian researchers find a crack in the wall of WHO’s top priority pathogens

SlyB protein acts as a lifebuoy and protects bacteria from dying

December 14, 2023

VIB research tackles the bottleneck of time-resolved Cryo-EM 

VIB research tackles the bottleneck of time-resolved Cryo-EM 

New microfluidic device improves the time resolution of trEM almost tenfold.

August 18, 2023

Decoding the satiety signal

Decoding the satiety signal

Research reveals how leptin and its receptor work together to regulate hunger signals

March 24, 2023

Jan Steyaert receives prestigious Gabbay Award for pioneering work on Nanobody® technology

Jan Steyaert receives prestigious Gabbay Award for pioneering work on Nanobody® technology

Steyaert is the first Belgian scientist to receive the prestigious American award for outstanding science with a translational character

October 28, 2022

Will llama antibodies help to treat Parkinson's disease?

Will llama antibodies help to treat Parkinson's disease?

Nanobodies® to target Parkinson's disease

February 28, 2022

About VIB

VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms. Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – and supported by a solid funding program, VIB unites the expertise of all its collaborators and research groups in a single institute. VIB’s technology transfer activities translate research results into concrete benefits for society such as new diagnostics and therapies and agricultural innovations. These applications are often developed by young start-ups from VIB or through collaborations with other companies. This also leads to additional employment and bridges the gap between scientific research and entrepreneurship. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information. 

More info can be found on www.vib.be.

Contact